Literature DB >> 20841468

Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.

Xiaoyun Cheng1, Weiya Xia, Jer-Yen Yang, Jennifer L Hsu, Jing-Yu Lang, Chao-Kai Chou, Yi Du, Hui-Lung Sun, Shannon L Wyszomierski, Gordon B Mills, William J Muller, Dihua Yu, Mien-Chie Hung.   

Abstract

Amplification or overexpression of murine double minute 2 (MDM2) promotes a variety of human tumors by degrading tumor suppressor proteins such as p53. Phosphorylation of MDM2 on Ser(166) and Ser(186) by the survival kinase Akt inhibits p53-mediated apoptosis. However, it is unclear whether this pathway contributes to normal or malignant pathophysiology in vivo. To address these questions, we generated transgenic mice expressing the Akt-phosphorylated form of MDM2 (MDM2DDS166D/S186D) in the mammary epithelium. Activation of MDM2 delayed mammary gland involution and accelerated tumor progression in mouse mammary tumor virus/neu transgenic mice by inhibiting apoptosis in a manner associated with decreased p53 expression. Our findings offer in vivo evidence that activation of MDM2 by Akt contributes to mammary development and tumorigenesis.
© 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841468      PMCID: PMC2948588          DOI: 10.1158/0008-5472.CAN-09-3231

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  Cell cycle and death control: long live Forkheads.

Authors:  Boudewijn M T Burgering; Geert J P L Kops
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

2.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

3.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

4.  HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.

Authors:  B P Zhou; Y Liao; W Xia; Y Zou; B Spohn; M C Hung
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

5.  Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.

Authors:  J Hutchinson; J Jin; R D Cardiff; J R Woodgett; W J Muller
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

8.  Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

Authors:  K Lundgren; R Montes de Oca Luna; Y B McNeill; E P Emerick; B Spencer; C R Barfield; G Lozano; M P Rosenberg; C A Finlay
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

9.  Phosphorylation of HDM2 by Akt.

Authors:  Margaret Ashcroft; Robert L Ludwig; Douglas B Woods; Terry D Copeland; H Oliver Weber; Elizabeth J MacRae; Karen H Vousden
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

Review 10.  MDM2, an introduction.

Authors:  Tomoo Iwakuma; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

View more
  11 in total

1.  Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.

Authors:  Chun-Te Chen; Yi Du; Hirohito Yamaguchi; Jung-Mao Hsu; Hsu-Ping Kuo; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Mol Cancer Ther       Date:  2012-07-23       Impact factor: 6.261

Review 2.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

Review 3.  MDM2, MDMX and p53 in oncogenesis and cancer therapy.

Authors:  Mark Wade; Yao-Cheng Li; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

Review 4.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

5.  Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.

Authors:  O Bucur; A L Stancu; R Khosravi-Far; A Almasan
Journal:  Cell Death Dis       Date:  2012-02-02       Impact factor: 8.469

6.  Multipoint targeting of the PI3K/mTOR pathway in mesothelioma.

Authors:  S Zhou; L Liu; H Li; G Eilers; Y Kuang; S Shi; Z Yan; X Li; J M Corson; F Meng; H Zhou; Q Sheng; J A Fletcher; W-B Ou
Journal:  Br J Cancer       Date:  2014-04-24       Impact factor: 7.640

Review 7.  Mouse modelling of the MDM2/MDMX-p53 signalling axis.

Authors:  Nicole R Tackmann; Yanping Zhang
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

8.  Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.

Authors:  Antony S Tin; Anna H Park; Shyam N Sundar; Gary L Firestone
Journal:  BMC Biol       Date:  2014-09-12       Impact factor: 7.431

9.  MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.

Authors:  Inga Grünewald; Marcel Trautmann; Alina Busch; Larissa Bauer; Sebastian Huss; Petra Schweinshaupt; Claudia Vollbrecht; Margarete Odenthal; Alexander Quaas; Reinhard Büttner; Moritz F Meyer; Dirk Beutner; Karl-Bernd Hüttenbrink; Eva Wardelmann; Markus Stenner; Wolfgang Hartmann
Journal:  Oncotarget       Date:  2016-11-15

10.  Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells.

Authors:  Chuan Chen; Zhu Han; Minjie Yang; Zhongke Jiang; Xiuyuan Ou
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.